Irbesartan side effects by duration, gender and age - a phase IV clinical study of FDA data

Summary:

Side effects are reported by people who take Irbesartan. Common side effects include asthenia among females and abdominal pain among males.

The phase IV clinical study is created by eHealthMe based on 33,223 reports from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Sep, 20, 2023

33,223 people who take Irbesartan and have side effects are studied.

What is Irbesartan?

Irbesartan has active ingredients of irbesartan. It is often used in high blood pressure. eHealthMe is studying from 33,691 Irbesartan users for its effectiveness, alternative drugs and more.

Number of Irbesartan reports submitted per year:

* Approximation only. Some reports may have incomplete information.

Do you take Irbesartan?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

How the study uses the data?

The study is based on irbesartan (the active ingredients of Irbesartan) and Irbesartan (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered.

Related studies

Alternative drugs to, pros and cons of Irbesartan:

Irbesartan (33,691 reports)

Common Irbesartan side effects:

High blood pressure: 2,139 reports
Diarrhea: 1,897 reports
Fatigue (feeling of tiredness): 1,762 reports
Weakness: 1,598 reports
Breathing difficulty: 1,553 reports

All Irbesartan side effects from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

Stromectol and Lamisil drug interaction - 5 seconds ago
Aciphex and Therapeutic Response Delayed - 8 seconds ago
Duloxetine Hydrochloride and Zepatier drug interaction - 9 seconds ago
Dapagliflozin and Dizziness Aggravated - 13 seconds ago
Cardizem La vs. Vytorin - 26 seconds ago
Keppra Xr and Diverticulitis - 43 seconds ago
Oncovin and Numbness And Tingling - 47 seconds ago
Everolimus and Traumatic Lung Injury - 47 seconds ago
Acute Lymphocytic Leukemia (All) and Corneal Oedema - 49 seconds ago
Septra and Renagel drug interaction - 55 seconds ago